Long COVID risks are ‘distorted by flawed research’, study finds |


0

[ad_1]

The risk of contracting long COVID may have been exaggerated due to flawed research, leading to unnecessarily high levels of anxiety about suffering from it, a new study has suggested.

“Major flaws” in the literature on the condition likely exaggerated the true threat of contracting it, the new research argues.

For most people with COVID-19, they feel better within days or weeks, but some can have symptoms for longer than three months.

Fatigue, brain fog, chest pain and shortness of breath are reported as symptoms by those who have long COVID – which is officially known as post-acute sequelae of COVID-19 (PASC).

Now, researchers from the UK, along with Denmark and the USA, say “many scientific publications” overestimated the prevalence of long COVID because of “overly broad definitions, lack of control groups, inappropriate control groups, and other methodological flaws”.

Instead, the authors of the new study argue that the symptoms are common among upper respiratory viruses.

The research team said this lack of definition could end up leading to an increase in healthcare spending and more anxiety, as well as misdiagnoses and a diversion of funds.

Please use Chrome browser for a more accessible video player


1:14

Long COVID patient: ‘I lost my identity’

Concerns about too many symptoms and no required link to COVID

Published in the British Medical Journal’s Evidence-Based Medicine, the new paper looked at the definition of the condition by several global health organisations – including the National Institute for Health and Care Excellence (NICE) and the World Health Organisation (WHO).

The study argues none of the definitions “requires a causal link” to COVID-19 infection, adding any symptoms…

[ad_2]


Like it? Share with your friends!

0

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
khbrknews.com